Skip to content

Selective shoulder nerve blocks versus superior trunk block for pain relief in patients undergoing shoulder arthroscopy: a randomised feasibility trial

Suprascapular, Axillary and Lateral Pectoral Nerve Blocks (SAXIPec) Versus Superior Trunk Block for Shoulder Arthroscopy: A Randomised Feasibility Trial Evaluating Patient-Reported Outcomes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000878370
Acronym
SAXIPec
Enrollment
40
Registered
2026-07-17
Start date
2026-08-03
Completion date
2027-08-02
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Shoulder arthroscopy is commonly performed and postoperative pain can be substantial. The superior trunk block provides effective pain relief but may still impair diaphragm function in some patients. Although this is often well tolerated in healthy individuals, it may be clinically important in older or frail patients and those with pre-existing respiratory disease. Selective shoulder nerve blocks have been developed to target the nerves supplying the shoulder while potentially preserving diaphragm function, but clinical evidence supporting this approach remains limited. This randomised feasibility trial will compare the SAXIPec technique with the superior trunk block in adults undergoing elective shoulder arthroscopy. The primary aim is to determine whether a larger randomised controlled trial can be successfully conducted by assessing recruitment, successful delivery of the allocated intervention and completeness of follow-up. The study will also collect preliminary information on pain, quality of recovery, opioid consumption and diaphragm function to inform the design of a future definitive trial.

Interventions

Arm 1: Participants undergoing elective unilateral shoulder arthroscopy will receive the allocated ultrasound-guided regional anaesthesia immediately before induction of general anaesthesia in the anaesthetic bay. All nerve blocks will be performed by consultant anaesthetists experienced in ultrasound-guided regional anaesthesia using a sterile technique in keeping with ANZCA guidelines, and single-use 80mm needles with ropivacaine 0.5% administered by syringe under real-time ultrasound guidance

Arm 1: Participants undergoing elective unilateral shoulder arthroscopy will receive the allocated ultrasound-guided regional anaesthesia immediately before induction of general anaesthesia in the anaesthetic bay. All nerve blocks will be performed by consultant anaesthetists experienced in ultrasound-guided regional anaesthesia using a sterile technique in keeping with ANZCA guidelines, and single-use 80mm needles with ropivacaine 0.5% administered by syringe under real-time ultrasound guidance. SAXIPec group: ultrasound-guided posterior suprascapular nerve block (10 mL 0.5% ropivacaine), trans-quadrangular space axillary nerve block (7 mL 0.5% ropivacaine), and lateral pectoral nerve block (3 mL 0.5% ropivacaine). General anaesthesia will then be induced immediately after completion of the regional block. Surgery will proceed according to routine practice. General anaesthesia will otherwise be at the discretion of the treating anaesthetist, while postoperative multimodal analgesia will be standardised according to institutional protocol. Intervention fidelity will be assessed using study-specific REDCap electronic data collection forms completed by the treating anaesthetist performing the nerve block(s). The forms document completion of the allocated intervention, local anaesthetic volumes administered, and any protocol deviations or crossover. Access to the REDCap database is restricted to authorised study investigators.

Sponsors

St. Vincent's Hospital Melbourne
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Adults aged 18 years or older with American Society of Anesthesiologists (ASA) physical status I–III undergoing elective unilateral shoulder arthroscopy, able to provide written informed consent and complete study questionnaires.

Exclusion criteria

Contraindications to peripheral nerve block or local anaesthetic allergy; body mass index >45 kg/m²; pre-existing peripheral neuropathy or coagulation disorder; chronic pain or regular opioid use; significant systemic disease including moderate to severe pulmonary disease, chronic liver disease, congestive heart failure or renal impairment; known contralateral diaphragmatic dysfunction or previous phrenic nerve injury; impaired capacity to provide informed consent or complete study questionnaires; or emergency surgery.

Outcome results

None listed

Source: ANZCTR · Data processed: Aug 10, 2026